Liusheng Wu

机构：National University of Singapore, Peking University Shenzhen Hospital, Tsinghua University · ORCID：0000-0001-9580-2257

发表论文 59 篇 · 总被引 889 次 · h-index 12

代表论文

• Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD) (2023 · Biomedicines · 被引 112)
• Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity (2024 · Vaccines · 被引 108)
• Research progress of 3D-bioprinted functional pancreas and in vitro tumor models (2024 · International Journal of Bioprinting · 被引 71)
• RETRACTED: NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score (2024 · Heliyon · 被引 66)
• Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma (2024 · Translational Oncology · 被引 40)
• Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment (2024 · Journal of Functional Biomaterials · 被引 36)